PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,228,047 | +277.2% | 688,607 | +284.5% | 0.00% | – |
| Q2 2023 | $1,121,047 | -40.3% | 179,081 | -54.5% | 0.00% | – |
| Q1 2023 | $1,877,391 | +8.5% | 393,583 | +97.9% | 0.00% | – |
| Q4 2022 | $1,730,099 | -12.0% | 198,862 | +20.2% | 0.00% | – |
| Q3 2022 | $1,967,000 | -11.7% | 165,374 | +5.8% | 0.00% | – |
| Q2 2022 | $2,228,000 | -61.4% | 156,353 | -43.6% | 0.00% | -100.0% |
| Q1 2022 | $5,773,000 | +157.3% | 277,299 | +185.5% | 0.00% | – |
| Q4 2021 | $2,244,000 | +83.5% | 97,138 | +136.6% | 0.00% | – |
| Q3 2021 | $1,223,000 | +195.4% | 41,057 | +239.1% | 0.00% | – |
| Q2 2021 | $414,000 | – | 12,109 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
| OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
| Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
| Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
| COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
| Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
| RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
| PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |